CHA News Article

CDC Updates Guidance for Patients Under Investigation for MERS-CoV Infection

The Centers for Disease Control and Prevention (CDC) has updated its previously issued guidance on the MERS-CoV infection. Changes include removing references to the Republic of Korea, looser testing criteria and a title change that emphasizes the importance of using clinical judgement to guide testing. Patients in the U.S. who should be evaluated for MERS-CoV infection are those with both a clinical feature and epidemiologic risk. Patients should be evaluated and discussed with public health departments on a case-by-case basis if their clinical presentation or exposure history is equivocal (e.g., uncertain history of health care exposure). For complete interim guidance on patients under investigation and case definitions for MERS, visit the CDC website